Vincent Lagente

8.7k total citations
187 papers, 7.1k citations indexed

About

Vincent Lagente is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Vincent Lagente has authored 187 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Physiology, 72 papers in Pulmonary and Respiratory Medicine and 65 papers in Molecular Biology. Recurrent topics in Vincent Lagente's work include Asthma and respiratory diseases (70 papers), Phosphodiesterase function and regulation (28 papers) and Neuropeptides and Animal Physiology (25 papers). Vincent Lagente is often cited by papers focused on Asthma and respiratory diseases (70 papers), Phosphodiesterase function and regulation (28 papers) and Neuropeptides and Animal Physiology (25 papers). Vincent Lagente collaborates with scholars based in France, Brazil and United States. Vincent Lagente's co-authors include Elisabeth Boichot, Isabelle Guénon, Isabelle Couillin, M Corbel, Claude Bertrand, Thomas Gicquel, Charles Advenier, Bernhard Ryffel, Nicolas Germain and Valérie Quesniaux and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Gastroenterology.

In The Last Decade

Vincent Lagente

185 papers receiving 6.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Lagente France 44 2.3k 2.3k 1.9k 1.5k 711 187 7.1k
Marek Rola‐Pleszczynski Canada 49 2.0k 0.9× 1.4k 0.6× 1.8k 0.9× 2.4k 1.6× 331 0.5× 232 7.1k
John Morser United States 49 3.6k 1.6× 1.5k 0.6× 1.9k 1.0× 1.9k 1.3× 1.0k 1.4× 168 12.1k
Takahide Nagase Japan 41 2.8k 1.2× 2.4k 1.1× 1.8k 0.9× 1.2k 0.8× 756 1.1× 288 7.7k
Tim D. Oury United States 55 3.2k 1.4× 3.0k 1.3× 1.8k 0.9× 1.1k 0.7× 334 0.5× 139 9.6k
Mark A. Birrell United Kingdom 45 1.8k 0.8× 2.2k 1.0× 2.4k 1.3× 1.2k 0.8× 546 0.8× 124 6.1k
Julio Cortijo Spain 45 2.2k 1.0× 2.9k 1.3× 2.0k 1.0× 938 0.6× 214 0.3× 261 6.8k
János G. Filep Canada 59 2.9k 1.3× 1.2k 0.5× 1.8k 1.0× 2.8k 1.9× 491 0.7× 196 9.0k
Raouf A. Khalil United States 62 3.2k 1.4× 1.2k 0.5× 2.3k 1.2× 2.0k 1.4× 1.4k 1.9× 191 13.4k
Frans P. Nijkamp Netherlands 52 2.0k 0.9× 2.1k 0.9× 4.4k 2.3× 2.6k 1.7× 263 0.4× 306 9.3k
Takeshi Horio Japan 53 2.9k 1.3× 1.3k 0.6× 1.5k 0.8× 775 0.5× 349 0.5× 308 10.0k

Countries citing papers authored by Vincent Lagente

Since Specialization
Citations

This map shows the geographic impact of Vincent Lagente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Lagente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Lagente more than expected).

Fields of papers citing papers by Vincent Lagente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Lagente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Lagente. The network helps show where Vincent Lagente may publish in the future.

Co-authorship network of co-authors of Vincent Lagente

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Lagente. A scholar is included among the top collaborators of Vincent Lagente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Lagente. Vincent Lagente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Victoni, Tatiana, et al.. (2024). Effects of the nerve growth factor and its carrier protein on the inflammatory response from human monocytes. Fundamental and Clinical Pharmacology. 38(5). 940–945.
2.
Carvalho, Vinícius F., Emiliano Barreto, Tatiana Victoni, & Vincent Lagente. (2022). The Role of Oxidative Imbalance on Pulmonary Diseases. Oxidative Medicine and Cellular Longevity. 2022(1). 4 indexed citations
3.
Victoni, Tatiana, Emiliano Barreto, Vincent Lagente, & Vinícius F. Carvalho. (2021). Oxidative Imbalance as a Crucial Factor in Inflammatory Lung Diseases: Could Antioxidant Treatment Constitute a New Therapeutic Strategy?. Oxidative Medicine and Cellular Longevity. 2021(1). 6646923–6646923. 37 indexed citations
4.
Lagente, Vincent, et al.. (2020). Uvaol Improves the Functioning of Fibroblasts and Endothelial Cells and Accelerates the Healing of Cutaneous Wounds in Mice. Molecules. 25(21). 4982–4982. 15 indexed citations
5.
Dornas, Waleska, Denise Glaise, Ahmad Sharanek, et al.. (2018). Endotoxin regulates matrix genes increasing reactive oxygen species generation by intercellular communication between palmitate‐treated hepatocyte and stellate cell. Journal of Cellular Physiology. 234(1). 122–133. 5 indexed citations
6.
Robert, Sacha, Thomas Gicquel, Tatiana Victoni, et al.. (2016). Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis. Bioscience Reports. 36(4). 144 indexed citations
7.
Gasse, Paméla, Nicolas Riteau, Rachel Vacher, et al.. (2011). IL-1 and IL-23 Mediate Early IL-17A Production in Pulmonary Inflammation Leading to Late Fibrosis. PLoS ONE. 6(8). e23185–e23185. 175 indexed citations
8.
Couillin, Isabelle, Virginie Vasseur, Sabine Charron, et al.. (2009). IL-1R1/MyD88 Signaling Is Critical for Elastase-Induced Lung Inflammation and Emphysema. The Journal of Immunology. 183(12). 8195–8202. 85 indexed citations
9.
Gasse, Paméla, Nicolas Riteau, Sabine Charron, et al.. (2009). Uric Acid Is a Danger Signal Activating NALP3 Inflammasome in Lung Injury Inflammation and Fibrosis. American Journal of Respiratory and Critical Care Medicine. 179(10). 903–913. 346 indexed citations
10.
Barreto, Emiliano, Stella Regina Zamunér, Ana Lucia A. Pires, et al.. (2008). Suppressive effects of nitric oxide‐releasing prednisolone NCX‐1015 on the allergic pleural eosinophil recruitment in rats. Clinical & Experimental Allergy. 38(11). 1830–1837. 12 indexed citations
11.
Fiévez, Laurence, et al.. (2006). Effects of the MMP inhibitor GM-6001 on emphysema development, infllammation and MMPs activity induced by cadmium in rats. Open Repository and Bibliography (University of Liège). 1 indexed citations
12.
Corbel, M, Sylvie Caulet-Maugendre, Nicolas Germain, Vincent Lagente, & Elisabeth Boichot. (2003). Enhancement of gelatinase activity during development of subepithelial fibrosis in a murine model of asthma. Clinical & Experimental Allergy. 33(5). 696–704. 17 indexed citations
13.
Corbel, Marianne, et al.. (2001). Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. The Journal of Pathology. 193(4). 538–545. 114 indexed citations
14.
Germain, Nicolas, et al.. (1998). Selective phosphodiesterase inhibitors modulate the activity of alveolar macrophages from sensitized guinea-pigs. European Respiratory Journal. 12(6). 1334–1339. 16 indexed citations
15.
Coqueret, Olivier, Danièle Demarquay, & Vincent Lagente. (1996). Role of cyclic AMP in the modulation of IgE production by the beta 2-adrenoceptor agonist, fenoterol. European Respiratory Journal. 9(2). 220–225. 20 indexed citations
16.
Lagente, Vincent, et al.. (1995). Modulation of Cytokine-Induced Eosinophil Infiltration by Phosphodiesterase Inhibitors. American Journal of Respiratory and Critical Care Medicine. 151(6). 1720–1724. 69 indexed citations
17.
Lagente, Vincent, et al.. (1994). Effects of isozyme-selective phosphodiesterase inhibitors on eosinophil infiltration in the guinea-pig lung. European Journal of Pharmacology. 255(1-3). 253–256. 47 indexed citations
18.
Braquet, P., Bernard Dugas, Nathalie Paul‐Eugène, et al.. (1991). Enhancement of the expression and release of the human monocyte low affinity IgE receptor (FcεRII/CD 23) by β2‐adrenoceptor agonists. Clinical & Experimental Allergy. 21(s1). 268–271. 4 indexed citations
19.
Pons, Françoise, Caroline Touvay, Vincent Lagente, Jean Michel Mencia‐Huerta, & P. Braquet. (1991). Comparison of the effects of intra‐arterial and aerosol administration of endothelin‐1 (ET‐1) in the guinea‐pig isolated lung. British Journal of Pharmacology. 102(4). 791–796. 24 indexed citations
20.
Lagente, Vincent, Paul Hadváry, M. Cirino, et al.. (1988). Interference of the Paf antagonist Ro 19–3704 with Paf and antigen‐induced bronchoconstriction in the guinea‐pig. British Journal of Pharmacology. 94(1). 27–36. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026